- Pilot Extension for Individual Patient Input to the Common Drug Review
- The Common Drug Review (CDR) is extending its pilot to receive patient input submissions from individual patients and caregivers until August 3, 2015.
- Pilot Extension for Patient Input for Therapeutic Reviews
- CADTH implemented a pilot process for receiving patient input submissions for therapeutic reviews from patient groups in August 2014.
- CADTH has extended this pilot until November 30, 2015 to further assess the effectiveness of the process.
- Answering Multiple Calls for Patient Input
- CADTH suggests the following for patient groups when multiple drugs, with similar indications, arrive to the CDR in close succession:
- Focus efforts on answering section 3 of the template on expectations for the new drug and reporting any patient experiences with the drug in review.
- Reuse the perspectives and quotes from past submissions to answer sections 1 and 2.
- Reuse quotes or comments that are still the most relevant to the patient community as new treatments become available.
- Consider a joint submission with another patient group to help share the workload.
- CADTH suggests the following for patient groups when multiple drugs, with similar indications, arrive to the CDR in close succession:
- Reminder: Stakeholder Engagement Session — February 5, 2015
- CADTH is inviting stakeholders to attend an information and feedback session regarding phase II of the transition of pCODR to CADTH, including the work being carried out to better align the pCODR and CADTH Common Drug Review processes. Registration is required.
For more information, please visit the CADTH website.